Bioactive food chemicals are substances present in food that are capable of interacting with living cells causing changes in physiological functions. Salicylic acid (SA), a plant hormone involved in plant immune response, is one such bioactive food chemical. Aspirin, a commercially available SA, might play beneficial roles in cardiovascular health and colon cancer. It may also cause urticaria, angioedema, asthma, and gastrointestinal symptoms in SA-sensitive individuals. Dietary SA might exert similar beneficial effects and/or may induce similar symptoms in hypersensitive individuals. Food-related SA sensitivity in relation to gastrointestinal symptoms is not well documented besides a few self-reported questionnaires and the knowledge that low doses of aspirin (equivalent of high dietary intake) can cause gastrointestinal injury. The only direct evidence that suggests benefits of reducing dietary SA was reported in asthmatic individuals. Although SA sensitivity in relation to gut symptoms in susceptible individuals is accepted by clinicians, the detection of this disease remains a challenge because of the complicated nature of dietary challenges and the risk of oral aspirin provocation tests in patients with severe hypersensitivity reactions. Given the non-IgE mediated nature of the disease, in vitro assays like basophil activation may have failed to produce reliable results. However, given the simplicity of this assay, further studies need to be formulated to firmly establish its reliability. Formulation of proper dietary strategies for symptom control is also impossible given the controversial and scant nature of the data on SA content of food. This issue needs to be resolved to formulate proper dietary strategies for effective symptom control.
Introduction
Much of the attention to food as inducers of gastrointestinal symptoms has been restricted to carbohydrates (such as FODMAPs) and proteins (such as gluten). However, food contains a large array of chemicals; some of which are bioactive. These are of relevance because there is increasing data to support a rich sampling of the luminal chemical environment by receptors along the gastrointestinal tract and subsequent binding and activation of those receptors can lead to release of neurotransmitters and other effector molecules that can influence the enteric nervous system and immunoinflammatory cells. Indeed, food chemicals have been blamed for multiple illnesses including behavioral and hypersensitivity/allergic-type conditions. Gut symptoms as occurring in functional gastrointestinal disorders are no exception, and complex dietary regimens have been proposed and are currently being used without more than anecdotal evidence of efficacy. This review will focus on salicylic acid (SA), which is strongly implicated as an inducer of gastrointestinal symptoms in susceptible individuals.
Bioactive compounds
A bioactive compound is defined as "… a compound which has the capability and the ability to interact with one or more component(s) of the living tissue by presenting a wide range of probable effects. The origin of these substances can be natural: terrestrial or aquatic; a plant, animal or other source (e.g. microorganisms) or synthetic: partially or totally …".
1 Synthetic food chemicals include food additives that help delay growth of microorganisms, maintain nutritional values and other properties of food products, and prolong the shelf life and quality of foods. [2] [3] [4] On the other hand, naturally occurring food chemicals are endogenously produced by plants and animals, and humans are exposed to these chemicals through their diet.
Salicylates or SA (C 7 H 6 O 3 , 2-hydroxybenzoic acid) is one such naturally occurring food chemical. It is a major plant hormone-a phenolic acid defined as a non-flavonoid polyphenolic compound. 5 It occurs in two major forms in plants-free form as free SA and bound form as its carboxylated esters (methyl salicylate also called "oil of wintergreen") and phenolic glycosides (salicin). 6 SA regulates various stress responses in plants like resistance to pathogens, flowering, thermogenesis, senescence, and abiotic stress response. [7] [8] [9] [10] Figure 1 depicts the different forms of SA in plants.
Beneficial effects of salicylic acid
Salicylic acid has long been known for their curative properties. The leaves and barks of the willow tree, which were later on used to extract SA, were used by ancient Romans, Chinese, and native Americans to treat pain and fever. 11 In 1763, Edward Stone was able to favorably treat with a pulverized preparation of willow bark 50 malaria patients. Felix Hoffman (1987) synthesized the acetylated form of SA, and thus, acetylsalicylic acid was born and was named "aspirin" by Heinrich Dreser, the then head of pharmacology at Bayer and Co, Germany.
11 Figure 2 summarizes the history of SA from willow tree to aspirin.
Today, several beneficial roles of aspirin are known. The major ones include reducing risk of cardiovascular disease and of colorectal, prostrate, oesophageal, laryngeal, and gastric cancer. 12 SA at a concentration of >1 mmol/L in vitro can inhibit prostaglandins, thus exhibiting its anti-inflammatory effect. 13 Several other in vitro studies suggest that SA at a concentration of >10 mmol can regulate several cellular functions including apoptotic genes 14 and DNA mismatch repair. 15 
Adverse effects of salicylic acid
Despite the suggested beneficial roles of SA, several cases of adverse reactions to SA have been reported. The prevalence of hypersensitivity reactions to aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs) varies between 10% and 20% in adult asthmatics and 0.6% to 2.5% in the general population. 16, 17 The classic triad of SA intolerance includes urticaria, angioedema, and non-allergic asthma. 18 Asthma is often accompanied by recurrent rhinitis and nasal polyposis. These are considered as systemic inflammation due to the general immune response of the entire organism. 19 Local inflammation of the gastrointestinal tract is also manifested, including abdominal pain, diarrhea, fibrosis and bloating. 19 Cases of salicylate hypersensitivity are well documented in ailments of skin (urticaria and angioedema) and respiratory tract (rhinitis and asthma). In susceptible individuals with asthma, aspirin can trigger respiratory tract disorders known as aspirinexacerbated respiratory disease (AERD). Symptoms include asthma, rhinosinusitis, and nasal polyps. A recent systematic review and meta-analysis determined the mean provocation dosage for aspirin synthesizing data from 21 blinded, controlled, oral provocation tests with aspirin on 470 subjects, and 11 observational studies with self-reported questionnaires in more than 11 000 people. 20 Forced expiratory volume (FEV) was used as the parameter for grouping patients. This study reported mean provocation dosage for aspirin ranging from 62 to 108 mg/day (FEV1 ≥15% to FEV1 ≥25%) for adults and 20.6 mg/day for children. The lower dosage of 62 mg is of clinical relevance as the lowest dosage prescribed for lowering cardiovascular risk is 75 mg, and hence, caution should be administered while recommending this preventive therapy.
Salicylic acid and gastrointestinal symptoms
Cases of salicylate sensitivity with regard to gastrointestinal symptoms especially functional gut disorders are not well documented. Raithal et al. 2005 suggested that about 2.1% (7 of 332 patients) of patients with Crohn's disease and 7.4% (16 of 215 patients) of patients with ulcerative colitis are salicylate/NSAID intolerant as diagnosed by history and/or rechallenge methodology. In a selfreported questionnaire survey of patients with irritable bowel Salicylates and irritable bowel syndrome S Malakar syndrome (IBS), 12% of 643 participants reported IBS symptoms resulting from use of NSAIDs. These patients were also found to have sensitivity to a number of food items. 21 A cross-sectional population study based on a self-reported bowel disease questionnaire found association of high-dosage aspirin (greater than seven tabs per week) with bloating (OR = 1.18 [1.02-1.37]). 22 Non-IBS chronic constipation was found to be associated with use of one to two tablets of aspirin per week (OR = 1.7 [1.0-2.7]) and with NSAIDs (OR = 1.8 [1.1-3.0] ). 23 With low-dose aspirin intake, non-symptomatic gastroduodenal ulcers, 24 gastric damage (10 mg/day) in healthy individuals, 25 26 Whether these beneficial and adverse effects of aspirin can be extended to food SA is controversial. Increased concentration of serum and urine SA, and its metabolites have been observed in several studies after consumption of SA-rich foods.
27-31 Serum SA levels in people on low doses of aspirin (75 mg/day) recommended for lowering the risk of heart disease and cancer ranged from 0.23 to 25.4 μmol/L and slightly overlapped with serum SA levels in vegetarians on a highly spicy diet (Table 1) . 30 In human cancer cell lines, a very low concentration of aspirin (0.1 mmol/L) reduced the expression of Cox-2 mRNA, which is expressed in inflammatory cells, inhibiting prostaglandin synthesis and preventing conversion of arachidonic acid to carcinogenic cyclic prostanoids. 32 In light of this observation, it was suggested that salicylates from dietary sources may help in cancer prevention. 33 So there may be health benefits of dietary SA mainly from gradual accumulation of SA through diet over several meals in a day. However, whether such high concentrations can be obtained only from meals is controversial.
The evidence for a role of food salicylates causing hypersensitivity symptoms is mostly anecdotal. The only direct evidence found on dietary SA causing hypersensitivity reactions was the study on AERD patients (Sommer et al. 2015) . A 12-week randomized, single blind, crossover pilot study was conducted with 10 AERD patients presented with rhinosinusitis, nasal polyposis, and asthma. 34 They were challenged with 6 weeks of either habitual diet or a low salicylate diet (0.01-0.09 mg SA per serve). They were assessed on asthma control questionnaire, nasal sinus symptom score, sino-nasal outcome test, and endoscopic evaluation of paranasal sinuses and nasal cavity (POSE) at three time points (baseline, 6 weeks, and 12 weeks). Significant improvement was observed on a low SA diet for all assessments except on the asthma control score-nasal sinus symptom score (P = 0.019), sino-nasal outcome test (P = 0.005), and POSE (0.002). Although there was some reduction in symptom scores in AERD patients on a low SA diet, the study had several limitations. The small sample size (n = 10) may not be reflective of the larger population. The authors have pointed out that a response bias may exist as it was not feasible to blind the patients completely while answering the questionnaires. Not only was the low salicylate diet formulated based on the highly scant and controversial previous literature, 29 but also no nutritional analysis of their habitual diet was reported and dietary compliance was not taken into account. Hence, proper clinical studies need to be conducted addressing these issues in AERD populations as well as in other populations showing SA hypersensitive reactions.
Detecting and managing salicylate sensitivity in clinical practice
The current status for detecting SA sensitivity is highly challenging. Aspirin hypersensitivity is detected by oral provocation tests, which is contraindicated in patients with severe hypersensitivity reactions. On the other hand, food salicylate sensitivity is detected by the highly time-consuming and challenging "elimination and rechallenge" dietary procedure. The whole process can take up to 10 months. It involves weeks of testing each with wheat, dairy, and soy, followed by salicylates and amines, the most common sources of problems. Three-day challenges then occur sequentially for glutamates, antioxidants, preservatives, and coloring agents. Food chemicals like salicylates can be tested using double-blind capsules, but most challenges are unblinded in clinical practice. Eventually, the chemical groups that appear to cause symptoms are identified, and a diet is designed for the patient based upon food composition tables derived from multiple sources. There is a wide variation in the content of food chemicals in these tables, especially salicylates, presumably related to methodological issues. 29 The majority of the patients who follow the recommended dietary plan often report to have considerable alleviation of symptoms, although no outcome data have been formally published. Also, the strictest restriction of food chemicals create a diet low in flavors and colors, making it unpalatable and challenging to comply with over the long periods of elimination and rechallenge phase. The nutritional adequacy of this dietary therapy in pediatric patients has been recently questioned. 35 Only observational studies have been performed in utilizing this low chemical diet, and the outcome data have not been formally published.
More recently, the basophil activation test (BAT) has been suggested to detect food chemical sensitivity with more sensitivity and specificity. The BAT has been traditionally used for detecting IgE-mediated true allergic reactions with high specificity and sensitivity for food allergies like milk 36 and wheat gluten. 37 However, the reliability of using BAT in detecting non-IgE-mediated hypersensitivity remains controversial. Some studies have reported successful results with sensitivity ranging from 43% 38 to 78% 39 and specificity range from 50% 40 to 100%. 38 Several other studies have also reported BAT to be of no clinical benefit. For example, Celik et al. 2009 41 reported a poor sensitivity of 30% and a specificity of 40%; Malbran 2006 42 found no mean difference between the mean activation of hypersensitive and healthy controls, while Ariza et al. 2014 43 reported 100% sensitivity but 20% specificity rendering the assay of no clinical value.
The beneficial role of SA and its adverse reactions in hypersensitive individuals are accepted amongst clinicians. Also, there is evidence of adverse reactions on low-dose aspirin in healthy individuals. So recommendation of diets complementary to a lower dose of aspirin may be beneficial. Also in SA-sensitive individuals, elimination diet is recommended for symptom control. Hence, to formulate proper dietary strategies information on SA content of food is essential. There is a considerable controversy regarding the SA content of commonly consumed food items. 29 If that is not resolved, it is not possible to determine what foods may give optimal health benefits or whether they can induce symptoms or even low-grade inflammation in sensitive individuals.
Conclusions
If they are capable of producing hypersensitive reactions, it is important to know if restriction of SA will alleviate those symptoms. Currently, the dietary approach recommended to control hypersensitive reactions are challenging to both the dietitians and the patients. So it is necessary to identify the patients who will be benefitted from such an approach. The only way to determine this is via the very complicated and lengthy "elimination and rechallenge" protocol. Because the BAT has shown some potential in detecting SA hypersensitivity and is comparatively simpler to implement, it is important to firmly establish its reliability in detecting non-IgE-mediated reactions. There is also paucity of data on the effect of altering dietary SA on clinical outcomes that needs to be addressed.
